With an ecosystem of high-throughput instruments generating multi-terabyte datasets, the data management capacity of a leading global gene therapy innovator had reached breaking point. It was too slow ...
Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...
In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...
Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate ...
4d
Smart materials and drug delivery could exploit lipid molecules that reorganize at drying interfaces
Minor changes in moisture level can promote lipid molecules to reorganize themselves in biomaterial or biomembranes. This can affect how the skin, lungs and tear film protect us from dehydration. This ...
A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results